Stay updated on Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.2 to v3.6.3, indicating a recent update to the page or its documents. This change reflects versioning and does not modify study details or participant information.
    Difference
    0.0%
    Check dated 2026-07-03T23:23:48.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2. This reflects a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-06-26T20:41:28.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page adds a recruitment status note indicating no participants are being recruited and introduces user guidance sections to help readers understand and navigate the study record. It also updates a heading format and revision tags, reflecting minor technical edits.
    Difference
    0.2%
    Check dated 2026-06-12T14:50:42.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, signaling a new version of the ClinicalTrials.gov page. This is a deployment-level update and does not modify the study data or presented details.
    Difference
    0.0%
    Check dated 2026-06-05T09:56:15.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.5.4) replacing the previous v3.5.3, indicating an updated software release.
    Difference
    0.0%
    Check dated 2026-05-15T04:59:36.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The sponsor designation in the study details was updated from Verona Pharma plc to Verona Pharma, Inc., a subsidiary of Merck & Co., Inc., Rahway, NJ, signaling a change in the corporate structure and sponsor organization used for the trial.
    Difference
    0.1%
    Check dated 2026-05-08T00:26:51.000Z thumbnail image

Stay in the know with updates to Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.